News

Chemtura Reports Q3 2012 Financial Results

DSM Q3 Operating Profit Misses Forecast

Wolfgang Hapke to Become Head of Human Resources of BASF

BASF Optimizes Its Organizational Structure

Oxea Plans Further Plant Expansion Projects in Bay City, Texas

Following the capacity increase of its syngas production facility in Bay City, Texas, USA, the chemical company Oxea is in the last stages of completion of a feasibility study of additional downstream plant expansion projects.

Drugmakers Offer to Cap Greece's Medicines Bill

Applikon, Thermo Fisher Sign Bilateral Supply Agreement

Germany's Merck Halts Supply of Cancer Drug to Greek Hospitals

India Revokes Roche Patent in New Blow for Big Pharma

Dendreon Posts Better-Than-Expected Q3 Results

Chevron Profit Down on Reduced Output, Weak Refining

EMD Millipore, Sistemic Collaborate to Identify Control Markers for Stem Cell Production

GlaxoSmithKline Wins Top Prize at IChemE Awards

SAFC, CrystalGenomics Sign Collaboration Agreement

Europe Approves High-Price Gene Therapy

Vertex Posts Q3 Loss as Hepatitis Drug Sales Plunge

Teva Pharmaceutical Adjusted Profit Tops Estimates

Rosneft's $5.8 Billion Q3 Net Profit Beats Borecasts

Russia's Acron Agrees $1.5 Billion Potash Project Financing

Pfizer Quarterly Revenue Fall Far Short of Forecasts

Refining Underpins Shell Q3 as Output Stalls

Sanofi Draws Fire Over Cost of MS Drug Lemtrada

Wacker Expands Collaboration with DKSH in Southeast Asia

Symrise Attracted by Growth in Cosmetic Ingredients

BASF Opens Global R&D Center for Mining in Australia

Air Liquide Major Licensor for Petrobras Gas-to-Chemicals Complex in Brazil

AstraZeneca Deepens Collaboration with Academia

Top Medical Innovations Address Headache, Diabetes, Cancer

Norway's Orkla Beats Forecasts with Q3 Profit

Clariant Profit Weakens with World Economy

Switzerland's Lonza to Cut 500 Jobs

Strong Refining Margins Boost Total Q3

Potash Corp in Merger Talks with Israel Chemicals

EU Lagging in Controls Over Hazardous Chemicals

Dow Chemical to Take Q4 Charge of up to $1.1 Billion